Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
GLP-1RAs aid in weight loss by regulating the gut-brain axis and interacting with leptin, while weight loss can alleviate the harmful effects of obesity on the body, particularly in knee OA, by reducing joint loading and inflammation
A drug named GSK-J4 was identified through the integrated screening of small-molecule inhibitor libraries and pharmaceutical-targeting CRISPR libraries
Impaired Amino Acid Absorption: Clinical studies have shown that in individuals with vitamin D deficiency, the expression of the neutral amino acid transporter SLC6A19 in the small intestine epithelial cells is reduced by 30%-50%
As such, GLP-1 not only represents a target for therapeutic interventions in the management of diabetes and obesity but also serves as a focal point for preventive strategies aimed at maintaining metabolic health and preventing the onset of metabolic disorders
10.1210/clinem/dgae917 J Clin Endocrinol Metab
Such an intervention resulted in significant effects on inflammatory and oxidative stress parameters and led to improvement of hypertension, according to the study
